BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 19850546)

  • 1. Plasma N-terminal pro-B-type natriuretic peptide concentration helps to predict survival in dogs with symptomatic degenerative mitral valve disease regardless of and in combination with the initial clinical status at admission.
    Serres F; Pouchelon JL; Poujol L; Lefebvre HP; Trumel C; Daste T; Sampedrano CC; Gouni V; Tissier R; Hawa G; Chetboul V
    J Vet Cardiol; 2009 Dec; 11(2):103-21. PubMed ID: 19850546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-terminal pro B-type natriuretic peptide and left ventricular diameter independently predict mortality in dogs with mitral valve disease.
    Moonarmart W; Boswood A; Luis Fuentes V; Brodbelt D; Souttar K; Elliott J
    J Small Anim Pract; 2010 Feb; 51(2):84-96. PubMed ID: 20070494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of plasma N-terminal pro-B-type natriuretic peptide concentration with mitral regurgitation severity and outcome in dogs with asymptomatic degenerative mitral valve disease.
    Chetboul V; Serres F; Tissier R; Lefebvre HP; Sampedrano CC; Gouni V; Poujol L; Hawa G; Pouchelon J-
    J Vet Intern Med; 2009; 23(5):984-94. PubMed ID: 19572913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lowered N-terminal pro-B-type natriuretic peptide levels in response to treatment predict survival in dogs with symptomatic mitral valve disease.
    Wolf J; Gerlach N; Weber K; Klima A; Wess G
    J Vet Cardiol; 2012 Sep; 14(3):399-408. PubMed ID: 22858663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of azotemia on serum N-terminal proBNP concentration in dogs with normal cardiac function: a pilot study.
    Schmidt MK; Reynolds CA; Estrada AH; Prosek R; Maisenbacher HW; Sleeper MM; Oyama MA
    J Vet Cardiol; 2009 May; 11 Suppl 1():S81-6. PubMed ID: 19394913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The combined prognostic potential of serum high-sensitivity cardiac troponin I and N-terminal pro-B-type natriuretic peptide concentrations in dogs with degenerative mitral valve disease.
    Hezzell MJ; Boswood A; Chang YM; Moonarmart W; Souttar K; Elliott J
    J Vet Intern Med; 2012; 26(2):302-11. PubMed ID: 22369312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical utility of serum N-terminal pro-B-type natriuretic peptide concentration for identifying cardiac disease in dogs and assessing disease severity.
    Oyama MA; Fox PR; Rush JE; Rozanski EA; Lesser M
    J Am Vet Med Assoc; 2008 May; 232(10):1496-503. PubMed ID: 18479239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diagnostic accuracy of different natriuretic peptides in the investigation of canine cardiac disease.
    Boswood A; Dukes-McEwan J; Loureiro J; James RA; Martin M; Stafford-Johnson M; Smith P; Little C; Attree S
    J Small Anim Pract; 2008 Jan; 49(1):26-32. PubMed ID: 18005104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of serum N-terminal pro-B-type natriuretic peptide concentration for differentiation of congestive heart failure from primary respiratory tract disease as the cause of respiratory signs in dogs.
    Oyama MA; Rush JE; Rozanski EA; Fox PR; Reynolds CA; Gordon SG; Bulmer BJ; Lefbom BK; Brown BA; Lehmkuhl LB; Prosek R; Lesser MB; Kraus MS; Bossbaly MJ; Rapoport GS; Boileau JS
    J Am Vet Med Assoc; 2009 Dec; 235(11):1319-25. PubMed ID: 19951101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of circulating amino terminal-pro-B-type natriuretic peptide concentration in dogs with respiratory distress attributable to congestive heart failure or primary pulmonary disease.
    Fine DM; DeClue AE; Reinero CR
    J Am Vet Med Assoc; 2008 Jun; 232(11):1674-9. PubMed ID: 18518809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) to distinguish between congestive heart failure and non-cardiac causes of acute dyspnea in cats.
    Fox PR; Oyama MA; Reynolds C; Rush JE; DeFrancesco TC; Keene BW; Atkins CE; Macdonald KA; Schober KE; Bonagura JD; Stepien RL; Kellihan HB; Nguyenba TP; Lehmkuhl LB; Lefbom BK; Moise NS; Hogan DF
    J Vet Cardiol; 2009 May; 11 Suppl 1():S51-61. PubMed ID: 19394287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of plasma N-terminal pro-B-type natriuretic peptide concentrations in dogs with and without cardiac disease.
    Ettinger SJ; Farace G; Forney SD; Frye M; Beardow A
    J Am Vet Med Assoc; 2012 Jan; 240(2):171-80. PubMed ID: 22217025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
    J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of cardiac biomarkers for death in a non-dialysis chronic kidney disease population.
    Vickery S; Webb MC; Price CP; John RI; Abbas NA; Lamb EJ
    Nephrol Dial Transplant; 2008 Nov; 23(11):3546-53. PubMed ID: 18562472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis.
    David S; Kümpers P; Seidler V; Biertz F; Haller H; Fliser D
    Nephrol Dial Transplant; 2008 Apr; 23(4):1370-7. PubMed ID: 18089624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The diagnostic relevance of NT-proBNP and proANP 31-67 measurements in staging of myxomatous mitral valve disease in dogs.
    Wolf J; Gerlach N; Weber K; Klima A; Wess G
    Vet Clin Pathol; 2013 Jun; 42(2):196-206. PubMed ID: 23614733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of N-terminal pro-brain natriuretic peptide in severe sepsis and septic shock.
    Varpula M; Pulkki K; Karlsson S; Ruokonen E; Pettilä V;
    Crit Care Med; 2007 May; 35(5):1277-83. PubMed ID: 17414731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal resistive index in 55 dogs with degenerative mitral valve disease.
    Chetboul V; Daste T; Gouni V; Concordet D; Trehiou-Sechi E; Serres F; Pouchelon JL; Germain CA; Layssol-Lamour C; Lefebvre HP
    J Vet Intern Med; 2012; 26(1):101-8. PubMed ID: 22111692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pro-B-type natriuretic peptide levels in acute decompensated heart failure.
    Waldo SW; Beede J; Isakson S; Villard-Saussine S; Fareh J; Clopton P; Fitzgerald RL; Maisel AS
    J Am Coll Cardiol; 2008 May; 51(19):1874-82. PubMed ID: 18466803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma N-terminal pro-brain natriuretic peptide: a marker of left ventricular hypertrophy in hypertrophic cardiomyopathy.
    Brito D; Matias JS; Sargento L; Cabral MJ; Madeira HC
    Rev Port Cardiol; 2004 Dec; 23(12):1557-82. PubMed ID: 15732658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.